Key Metrics
CiteScore 

3.7
H-Index 

95
Impact Factor 

< 5
SJR 

Q2Pharmacology (medical)

SNIP 

0.73
Recommended pre-submission checks
Powered by 

Topics Covered on International Clinical Psychopharmacology
International Clinical Psychopharmacology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1986 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in International Clinical Psychopharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in International Clinical Psychopharmacology
Not all antipsychotic polypharmacy is the same.
- 1 Sep 2026
- International clinical psychopharmacology
Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.
- 1 Sep 2026
- International clinical psychopharmacology
Defining treatment-resistant depression in a real-world setting: impact of a staging model on clinical features and treatment trajectories.
- 1 Sep 2026
- International clinical psychopharmacology
Resistant depression, biomarkers, and comorbidity in clinical practice.
- 1 Sep 2026
- International clinical psychopharmacology
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).
- 1 Sep 2026
- International clinical psychopharmacology
Drug development in autism spectrum disorder: genetic heterogeneity, failed trials, and the case for stratified pharmacotherapy.
- 1 Sep 2026
- International clinical psychopharmacology
Not all antipsychotic polypharmacy is the same.
- 1 Sep 2026
- International clinical psychopharmacology
Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.
- 1 Sep 2026
- International clinical psychopharmacology
Defining treatment-resistant depression in a real-world setting: impact of a staging model on clinical features and treatment trajectories.
- 1 Sep 2026
- International clinical psychopharmacology
Resistant depression, biomarkers, and comorbidity in clinical practice.
- 1 Sep 2026
- International clinical psychopharmacology
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).
- 1 Sep 2026
- International clinical psychopharmacology
Drug development in autism spectrum disorder: genetic heterogeneity, failed trials, and the case for stratified pharmacotherapy.
- 1 Sep 2026
- International clinical psychopharmacology